These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35907662)

  • 1. Re: Pawel Rajwa, Benjamin Pradere, Giorgio Gandaglia, et al. Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2022;82:82-96.
    Murthy V; Chilukuri S; Maitre P
    Eur Urol; 2022 Oct; 82(4):e105-e106. PubMed ID: 35907662
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Francesco Montorsi, Armando Stabile, Elio Mazzone, Giorgio Gandaglia, and Alberto Briganti's Letter to the Editor re: Deepika Reddy, Max Peters, Taimur T. Shah, et al. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience. Eur Urol 2022;81:407-13.
    Reddy D; Ahmed HU
    Eur Urol; 2022 Sep; 82(3):e74-e75. PubMed ID: 35690513
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Giorgio Gandaglia, Alberto Briganti, Noel Clarke, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.01.039.
    Alongi F; Aiello D; Mazzola R; Cavalleri S
    Eur Urol; 2017 Aug; 72(2):e39-e40. PubMed ID: 28318727
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Alberto Martini, Giorgio Gandaglia, R. Jeffrey Karnes, et al. Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer. Eur Urol Oncol 2019;2:456-63.
    Giannarini G; Crestani A; Ficarra V
    Eur Urol Oncol; 2019 Jul; 2(4):472-473. PubMed ID: 31277786
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Pawel Rajwa, Daniele Robesti, Michael Chaloupka, et al. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.006.
    Onal C; Elmali A; Cem Guler O
    Eur Urol Oncol; 2024 Jun; 7(3):644-645. PubMed ID: 38365504
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
    Temiz MZ; Besiroglu H
    Eur Urol; 2018 May; 73(5):e130. PubMed ID: 29397220
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
    Dal Pra A; Supiot S; Ghadjar P
    Eur Urol; 2018 Feb; 73(2):e34-e35. PubMed ID: 28890243
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Jim C. Hu, Giorgio Gandaglia, Pierre I. Karakiewicz, et al. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol 2014;66:666-72.
    Froehner M; Wirth MP
    Eur Urol; 2014 Nov; 66(5):e85. PubMed ID: 24867149
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. Eur Urol 2017;72:289-92: Do the Data Violate Kaplan-Meier Assumptions?
    Mouracade P
    Eur Urol; 2017 Aug; 72(2):e29-e30. PubMed ID: 28238412
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Carlo A. Bravi, Nicoal Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9.
    Achard V; Dal Pra A; Zilli T
    Eur Urol; 2020 Dec; 78(6):e221-e222. PubMed ID: 33008661
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Giorgio Gandaglia G, Peter Albers, Per-Anders Abrahamsson, et al. Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019. Eur Urol 2019;76:142-50.
    Froehner M; Koch R; Thomas C
    Eur Urol; 2020 Jan; 77(1):e30. PubMed ID: 31836073
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti's Letter to the Editor, re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review, Meta-analysis. Eur Urol 2019;76:284-303: The choice of diagnostic test in prostate cancer is a balance of the risks and benefits: One size may not fit all.
    Kasivisvanathan V; Takwoingi Y; Emberton M; Moore CM
    Eur Urol; 2019 Nov; 76(5):e133-e134. PubMed ID: 31400949
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41.
    Aning J; McCoubrie P; Oxley J
    Eur Urol; 2020 Nov; 78(5):e198-e199. PubMed ID: 32839000
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Mustafa Z. Temiz and Huseyin Besiroglu's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2018 May; 73(5):e131-e132. PubMed ID: 29395499
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Pascal Mouracade's Letter to the Editor re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. Eur Urol 2017;72:289-92. Do the Data Violate Kaplan-Meier Assumptions?
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2017 Aug; 72(2):e31. PubMed ID: 28214034
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy. Eur Urol Oncol 2020;7:739-47.
    Morka N; Simpson BS; Emberton M; Norris JM
    Eur Urol Oncol; 2021 Feb; 4(1):127-128. PubMed ID: 33509743
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Alan Dal Pra, Stephane Supiot and Pirus Ghadjar's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2018 Feb; 73(2):e36-e37. PubMed ID: 28890246
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Michael Froehner, Manfred P. Wirth's letter to the editor re: Jim C. Hu, Giorgio Gandaglia, Pierre I. Karakiewicz, et al. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol 2014;66:666-72.
    Hu JC
    Eur Urol; 2014 Nov; 66(5):e86. PubMed ID: 24882671
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Vérane Achard, Alan Dal Pra, and Thomas Zilli's Letter to the Editor re: Carlo A. Bravi, Nicola Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9.
    Bravi CA; Montorsi F; Briganti A
    Eur Urol; 2020 Dec; 78(6):e223-e224. PubMed ID: 33023772
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41.
    Gandaglia G; Montorsi F; Briganti A
    Eur Urol; 2020 Nov; 78(5):e200. PubMed ID: 32800726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.